cbdc fed, Block

Huangshan Capsule: It is planned to distribute a cash dividend of 0.27 yuan for every 10 shares. Huangshan Capsule announced that the company held the board of directors and the board of supervisors on December 13, 2024, and reviewed and approved the profit distribution plan for the first three quarters of 2024. According to the plan, the company plans to distribute a cash dividend of RMB27 to all shareholders for every 10 shares based on the existing total share capital of 299 million shares, with a total cash dividend of RMB8,075,700. This profit distribution will not send bonus shares, and capital reserve will not be converted into share capital.Market News: US Secretary of State Blinken met with Iraqi Prime Minister in Baghdad to discuss the Syrian issue.Haitian Weiye, a soy sauce manufacturer, is reported to have hired a bank to handle the listing in Hong Kong. According to informed sources, Haitian Weiye, one of the largest condiment manufacturers in China, has hired CICC, Goldman Sachs and Morgan Stanley to handle the second listing in Hong Kong, which may raise at least $1.5 billion. According to people familiar with the matter, Haitian plans to submit a preliminary prospectus to the Hong Kong Stock Exchange as early as January.

Guoyuan Securities: A special dividend plan was drawn up and announced by Guoyuan Securities. On December 13, 2024, the company held the 20th meeting of the 10th Board of Directors and the 11th meeting of the 10th Board of Supervisors, at which the Proposal on Special Dividend Plan was reviewed and approved. As of September 30, 2024, the accumulated undistributed profit of the company was 7.743 billion yuan, and the accumulated distributable profit of the parent company was 5.262 billion yuan. In order to enhance the investor's sense of gain and improve the investor's return level, the company has drawn up a special dividend plan: based on the existing total share capital of 4.364 billion shares, a cash dividend of 0.60 yuan will be distributed to all shareholders for every 10 shares, and a total cash dividend of 262 million yuan will be distributed. No bonus shares will be distributed, and capital will not be increased from the provident fund.Luo Zhaohui, Director General of the United Nations Office, should meet with Egyptian Minister of Foreign Affairs and Immigration Abdul Ati by appointment. On December 13th, Luo Zhaohui, Director General of China International Development Cooperation Agency, should meet with Egyptian Minister of Foreign Affairs and Immigration Abdul Ati by appointment. Changshou Hailong, Director of Regional Division I, Li Ming, Director of International Cooperation Department, and Hanafi, Egyptian Ambassador to China, attended the meeting. Luo said that this year marks the 10th anniversary of the "China-Egypt Partnership Year" and the establishment of a comprehensive strategic partnership between the two countries. Under the strategic guidance of the leaders of the two countries, bilateral relations have achieved great-leap-forward development and achieved fruitful results. The General Office of the State Council is willing to work closely with the Egyptian Ministry of Foreign Affairs and the Ministry of International Affairs to implement the important consensus reached by the leaders of the two countries and the outcome of the Beijing Summit of the Forum on China-Africa Cooperation, deepen pragmatic cooperation in the development field between the two sides, and promote the common development of the global South. A thanked China for its long-term strong support for Egypt's economic and social development and improvement of people's livelihood, and expressed its willingness to work closely with China under the guidance of the consensus of the two heads of state to promote the joint construction of the Belt and Road Initiative and implement global development initiatives, continuously expand the breadth and depth of development cooperation between the two countries, and make new contributions to the development of comprehensive strategic partnership between the two countries.South Korean courts issued arrest warrants for police chief Zhao Zhihao and Seoul police chief Jin Feng Yong. On December 13th, local time, Seoul Central District Court issued arrest warrants for police chief Zhao Zhihao and Seoul police chief Jin Feng Yong. (CCTV News)

Nearly 30 listed companies announced after-hours that their products would be selected, and the tenth batch of centralized drug procurement (centralized drug procurement) organized by the state was opened in Shanghai yesterday. According to incomplete statistics, as of press time, it includes Fuyuan Pharmaceutical, Yifan Pharmaceutical, ST Tiansheng, Hokuriku Pharmaceutical, Haizheng Pharmaceutical, Zhongheng Group, Yuandong Bio, Kelun Pharmaceutical, China Resources Shuanghe, Sinopharm Modern, Lingkang Pharmaceutical, Xuantai Pharmaceutical, Jiuzhou Pharmaceutical, Kang Enbei, Laimei Pharmaceutical, Kanghong Pharmaceutical, Huasen Pharmaceutical, Borui Pharmaceutical, Xianzeng Pharmaceutical. Among them, Kelun Pharmaceutical announced that 12 kinds of drugs, such as sodium acetate Ringer injection, sodium bicarbonate Ringer injection and gliclazide tablets, were to be selected.Market News: Trump's assistant asked Trump if it was possible to abolish the Federal Deposit Insurance Corporation (FDIC).Kang Enbei: Amikacin Sulfate Injection is planned to win the bid for the tenth batch of national centralized drug purchase. On December 12th, Kang Enbei and its wholly-owned subsidiary Jinhua Kang Enbei participated in the bidding for the tenth batch of national centralized drug purchase organized by the National Joint Procurement Office for Centralized Drug Purchase and Use. After the bid opening and bid evaluation by the Joint Procurement Office, the company's product Amikacin Sulfate Injection plans to win the bid for this centralized procurement, and the supply provinces have been selected according to the market potential of each province. The successful results will be officially released after being publicized by the Joint Procurement Office. Amikacin sulfate injection is suitable for the treatment of serious infections caused by Pseudomonas aeruginosa, other Pseudomonas, Escherichia coli and other sensitive gram-negative bacilli and Staphylococcus (methicillin-sensitive strains). Compared with the original price, the price of the product to be selected this time has dropped to a certain extent.